Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellis Barbé

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
BJU International|August 14, 2021
Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort studyIris de Nie, Chantal M Wiepjes, Christel J M de Blok, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2025
Interassay Comparison With Digital Image Analysis of 4 Routine Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry Assays in Primary Breast Cancer and Its MetastasisMaaike Anna Hempenius, Mieke C Zwager, Jeppe Thagaard, et al.
BMJ Open|July 18, 2025
Preoperative partial breast reirradiation and repeat breast-conserving surgery in patients with recurrent breast cancer: the prospective single-arm REPEAT trial - a study protocolYasmin Civil, Lisca Wurfbain, Lysanne Jonker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2020
Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone TreatmentIris de Nie, Christel J M de Blok, Tim M van der Sluis, et al.
Radiology|March 4, 2025
The Diagnostic Accuracy of <sup>18</sup>F-FDG PET and <sup>18</sup>F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast CancerJelijn J Knip, Ramsha Iqbal, Emma C Bonjer, et al.
Brain, Behavior, & Immunity - Health|June 13, 2025
Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy - a feasibility trialAnna Ubink, Marieke R Ten Tusscher, Hans J van der Vliet, et al.
BMC Cancer|May 10, 2023
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocolYasmin A Civil, Arlene L Oei, Katya M Duvivier, et al.
Breast Cancer Research and Treatment|August 1, 2020
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability studyEmma J Groen, Jan Hudecek, Lennart Mulder, et al.
Endocrine-Related Cancer|July 25, 2019
The molecular genetic make-up of male breast cancerCathy B Moelans, Joep de Ligt, Petra van der Groep, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
BJU International|August 14, 2021
Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort studyIris de Nie, Chantal M Wiepjes, Christel J M de Blok, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2025
Interassay Comparison With Digital Image Analysis of 4 Routine Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry Assays in Primary Breast Cancer and Its MetastasisMaaike Anna Hempenius, Mieke C Zwager, Jeppe Thagaard, et al.
BMJ Open|July 18, 2025
Preoperative partial breast reirradiation and repeat breast-conserving surgery in patients with recurrent breast cancer: the prospective single-arm REPEAT trial - a study protocolYasmin Civil, Lisca Wurfbain, Lysanne Jonker, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2020
Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone TreatmentIris de Nie, Christel J M de Blok, Tim M van der Sluis, et al.
Radiology|March 4, 2025
The Diagnostic Accuracy of <sup>18</sup>F-FDG PET and <sup>18</sup>F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast CancerJelijn J Knip, Ramsha Iqbal, Emma C Bonjer, et al.
Brain, Behavior, & Immunity - Health|June 13, 2025
Exploring the effects of exercise on immune cell function and tumour infiltration in patients with breast cancer receiving neoadjuvant chemotherapy - a feasibility trialAnna Ubink, Marieke R Ten Tusscher, Hans J van der Vliet, et al.
BMC Cancer|May 10, 2023
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial-a study protocolYasmin A Civil, Arlene L Oei, Katya M Duvivier, et al.
Breast Cancer Research and Treatment|August 1, 2020
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability studyEmma J Groen, Jan Hudecek, Lennart Mulder, et al.
Endocrine-Related Cancer|July 25, 2019
The molecular genetic make-up of male breast cancerCathy B Moelans, Joep de Ligt, Petra van der Groep, et al.
Pageof 2